Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke

JAMA Neurology

Volumn 70, Issue 3, 2013, Pages 353-358

  Yeo, Leonard L L ^a   Paliwal, Prakash ^a   Teoh, Hock L ^a   Seet, Raymond C ^a   Chan, Bernard P L ^a   Liang, Shen ^c   Venketasubramanian, Narayanaswamy ^a   Rathakrishnan, Rahul ^a   Ahmad, Aftab ^a   Ng, Kay W P ^a   Loh, Pei K ^a   Ong, Jonathan J Y ^a   Wakerley, Benjamin R ^a   Chong, Vincent F ^b   Bathla, Girish ^b   Sharma, Vijay K ^a  

^a Division of Neurology Department of Medicine   (United States)

^b Department of Diagnostic Imaging ^*  (United States)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTION; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; TRANSCRANIAL DOPPLER; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84874901327     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/2013.jamaneurol.547     Document Type: Article

References (29)

1. Alexandrov AV, Molina CA, Grotta JC, et al CLOTBUST Investigators. Ultrasoundenhanced systemic thrombolysis for acute ischemic stroke. N Engl JMed. 2004; 351(21):2170-2178.
2. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38(3):967-973.
3. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73(13):1066- 1072.
4. Mazighi M, Serfaty JM, Labreuche J, et al RECANALISE Investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE Study): a prospective cohort study [published correction appears in Lancet Neurol. 2009;8(11):981]
5. Lancet Neurol. 2009;8(9):802-809.
6. Rubiera M, Alvarez-Sabín J, Ribo M, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke. 2005;36(7):1452-1456.
7. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59(6):862-867.
8. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
9. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41.
10. Chernyshev OY, Garami Z, Calleja S, et al. Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke. 2005;36(1):32-37.
11. Demchuk AM, Burgin WS, Christou I, et al. Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke. 2001;32(1):89-93.
12. Larrue V, von Kummer R, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001;32(2):438-441.
13. Molina CA, Montaner J, Abilleira S, et al. Time course of tissue plasminogen activatorinduced recanalization in acute cardioembolic stroke: a case-control study. Stroke. 2001;32(12):2821-2827.
14. Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR imaging vessel signs in hyperacute stroke patients imaged -3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005;26(3):618-624.
15. Burgin WS, Malkoff M, Felberg RA, et al. Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke. 2000;31(5):1128-1132.
16. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation. 2001;103 (24):2897-2902.
17. Ribo M, Alvarez-Sabín J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke. 2006;37(4):1000-1004.
18. Kimura K, Iguchi Y, Shibazaki K, et al. Early stroke treatment with IV t-PA associated with early recanalization. J Neurol Sci. 2010;295(1-2):53-57.
19. Yamaguchi T, Mori E, Minematsu K, et al Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37(7):1810-1815.
20. Ahmed N, Wahlgren N, Brainin M, et al SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke. 2009;40(7):2442-2449.
21. von Kummer R, Holle R, Rosin L, Forsting M, Hacke W. Does arterial recanalization improve outcome in carotid territory stroke Stroke. 1995;26(4):581587.
22. Sharma VK, Ng KW, Venketasubramanian N, et al. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Int J Stroke. 2011;6(6):523530.
23. Ueshima S, Matsuo O. The differences in thrombolytic effects of administrated recombinant t-PA between Japanese and Caucasians. Thromb Haemost. 2002; 87(3):544-546.
24. Iso H, Folsom AR, Sato S, et al. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb. 1993;13(6):783-790.
25. Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37(2):425-429.
26. Tsivgoulis G, Eggers J, Ribo M, et al. Safety and efficacy of ultrasoundenhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 2010;41(2):280-287.
27. Marks MP, Olivot JM, Kemp S, et al DEFUSE Investigators. Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations betweenMRangiography findings and perfusionand diffusion-weighted imaging in the DEFUSE Study. Radiology. 2008;249(2):614-623.
28. Sims JR, Rordorf G, Smith EE, et al. Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. AJNR Am J Neuroradiol. 2005;26(2):246-251.
29. Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366(12):1099- 1107.